Anti-rheumatic medications used to treat rheumatoid arthritis may help decrease the development of autoimmune thyroid illness, according to a new observational study.
According to a new observational study, anti-rheumatic medicines used to treat rheumatoid arthritis may help reduce the development of autoimmune thyroid disease.
According to the findings of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Centre, adding an immunomodulatory agent to treatment with the targeted tyrosine kinase inhibitor (TKI) cediranib did not improve outcomes in patients with differ